ImClone Investigational Site

San Antonio, Texas 78229

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Non Small Cell Lung Cancer, Sarcoma, Soft Tissue

Studies at this site

• Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients — Completed
• A Study of Olaratumab in Soft Tissue Sarcoma — Completed
• A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer — Completed
• A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer — Completed